These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11839384)

  • 1. Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels.
    Jeha S; Smith FO; Estey E; Shen Y; Liu D; Manshouri T; Albitar M
    Leuk Res; 2002 Apr; 26(4):399-402. PubMed ID: 11839384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
    Verstovsek S; Estey E; Manshouri T; Giles FJ; Cortes J; Beran M; Rogers A; Keating M; Kantarjian H; Albitar M
    Br J Haematol; 2002 Jul; 118(1):151-6. PubMed ID: 12100142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
    Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
    Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
    Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
    Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
    Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
    Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
    Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia.
    Fielder W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
    Leukemia; 1997 Aug; 11(8):1234-7. PubMed ID: 9264375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
    Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor.
    de Bont ES; Rosati S; Jacobs S; Kamps WA; Vellenga E
    Br J Haematol; 2001 May; 113(2):296-304. PubMed ID: 11380392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
    Bogic LV; Brace RA; Cheung CY
    Placenta; 2001 Apr; 22(4):265-75. PubMed ID: 11286562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia.
    Miraliakbari R; Francalancia NA; Lust RM; Gerardo JA; Ng PC; Sun YS; Chitwood WR
    Ann Thorac Surg; 2000 Jun; 69(6):1750-3; discussion 1754. PubMed ID: 10892919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KDR activation in astrocytic neoplasms.
    Carroll RS; Zhang J; Bello L; Melnick MB; Maruyama T; McL Black P
    Cancer; 1999 Oct; 86(7):1335-41. PubMed ID: 10506722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.